AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Immunocompromised Patients

ItAlian ReGistry Of pNeumoniA in immUnocompromised paTients (ARGONAUT) NCT06755814n/a1 site๐Ÿ“ Milan Societa Italiana di Pneumologia A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised NCT07013474Phase 3159 sites๐Ÿ“ Canoga Park๐Ÿ“ Granada Hills๐Ÿ“ La Jolla Pfizer ยท Tests: ibuzatrelvir, remdesivir, placebo for ibuzatrelvir, placebo for remdesivir Study of a Cohort of Non-HIV Immunocompromised Patients With Toxoplasmosis at the Strasbourg University Hospital NCT07299500n/a1 site๐Ÿ“ Strasbourg University Hospital, Strasbourg, France A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant NCT04006808Phase 1, Phase 231 sites๐Ÿ“ Brussels๐Ÿ“ Ghent๐Ÿ“ Leuven GlaxoSmithKline ยท Tests: PED-HZ/su Treatment of BK Virus Infection With CTL Cells in Immunocompromised Transplant Patients NCT04293042EARLY Phase 11 site๐Ÿ“ Philadelphia Children's Hospital of Philadelphia ยท Tests: BK-virus specific CTLs Analysis of the Specificity and Persistence of Nasal Immune Responses to Respiratory Viral Antigens in Immunocompromised and Healthy Cohorts NCT07295535n/a1 site๐Ÿ“ Pavia Fondazione IRCCS Policlinico San Matteo di Pavia Immunogenicity, Efficacy and Safety of Recombinant Herpes Zoster Vaccine in Frail Patients NCT07321808n/a1 site๐Ÿ“ Pavia Fondazione IRCCS Policlinico San Matteo di Pavia Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy NCT07426484Phase 42 sites๐Ÿ“ Boston๐Ÿ“ Boston Dana-Farber Cancer Institute ยท Tests: Cosibelimab, Prednisone, Sirolimus, Everolimus Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised Outpatients NCT07110636NA6 sites๐Ÿ“ San Francisco๐Ÿ“ New Orleans๐Ÿ“ Boston Karius, Inc. ยท Tests: Metagenomic plasma-based test for agnostic pathogen detection Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System NCT07042295Phase 255 sites๐Ÿ“ Birmingham๐Ÿ“ Gilbert๐Ÿ“ La Jolla National Cancer Institute (NCI) ยท Tests: Amivantamab and Recombinant Human Hyaluronidase, Biospecimen Collection, Cetuximab, Computed Tomography, Magnetic Resonโ€ฆ Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03) NCT05909332Phase 315 sites๐Ÿ“ Beijing๐Ÿ“ Chongqing๐Ÿ“ Fuzhou Fudan University ยท Tests: Antivascular therapy, Chemotherapy Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease NCT03425526Phase 11 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Allogeneic Adenovirus-specific Cytotoxic T Lymphocytes Clinical Study on Immunogenicity and Safety of Lyophilized Vero Cell-Derived Human Rabies Vaccine in Special Populations NCT07120464n/a1 site๐Ÿ“ Shenzhen Liaoning Chengda Biotechnology CO., LTD ยท Tests: Observation Only Individualised Dose Optimisation of Ganciclovir in Immunocompromised Children Trial (ID-MAGIC) NCT06574789Phase 27 sites๐Ÿ“ Sydney๐Ÿ“ Sydney๐Ÿ“ Brisbane Murdoch Childrens Research Institute ยท Tests: Standard dosing of IV ganciclovir, Personalised dosing of IV ganciclovir Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals NCT06817889Phase 23 sites๐Ÿ“ Duarte๐Ÿ“ Houston๐Ÿ“ Seattle Fred Hutchinson Cancer Center ยท Tests: Remdesivir, Survey Administration, Biospecimen Collection, Nasal Swab HBV Reactivation in Immunocompromised Patients (REANT STUDY) NCT07529171n/a16 sites๐Ÿ“ Adana๐Ÿ“ Ankara๐Ÿ“ Ankara YaลŸar Bayฤฑndฤฑr, MD ยท Tests: Antiviral Shingrix in Renal Transplant Recipients NCT04128189Phase 34 sites๐Ÿ“ Aurora๐Ÿ“ Atlanta๐Ÿ“ Boston University of Colorado, Denver ยท Tests: Shingrix Cologne Cohort of Neutropenic Patients (CoCoNut) NCT01821456n/a1 site๐Ÿ“ Cologne University Hospital of Cologne ยท Tests: Antiinfectives Chronic Pulmonary Aspergillosis and Ambisome Aerosol with Itraconazole NCT03656081Phase 31 site๐Ÿ“ Poitiers Poitiers University Hospital ยท Tests: inhaled Ambisomeยฎ, inhaled placebo, Itraconazole Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study NCT03808922Phase 328 sites๐Ÿ“ Duarte๐Ÿ“ Sacramento๐Ÿ“ Chicago Ansun Biopharma, Inc. ยท Tests: DAS181, Placebo, DAS181 COVID-19, DAS181 OL OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled Strategy Trial NCT05587894Phase 218 sites๐Ÿ“ Bordeaux๐Ÿ“ Bordeaux๐Ÿ“ Dijon ANRS, Emerging Infectious Diseases ยท Tests: Paxlovid 5 days, Paxlovid 10 days, Veklury Thymalfasin for Immune Recovery in Adults With Sepsis NCT07866118NA1 site๐Ÿ“ Shanghai Shanghai Zhongshan Hospital ยท Tests: Thymalfasin (Thymosin alpha 1, Ta1) Characterizing Diversity and Antifungal Resistance in Immunocompromised ICU Patients With Respiratory Tract Infections NCT06387667NA1 site๐Ÿ“ Asyut New Valley University ยท Tests: Complete blood count, C-reactive protein, urea, creatinine, Random blood glucose (RBG), aspartate aminotransferase (ASTโ€ฆ Aztreonam-Avibactam in Immunocompromised Hosts NCT07890480n/a1 site๐Ÿ“ Buenos Aires Centro de Educaciรณn Medica e Investigaciones Clรญnicas Norbeโ€ฆ ยท Tests: Aztreonam-Avibactam, Ceftazidime-Avibactam Plus Aztreonam Immunosuppression and Intensive Care Unit-acquired Multidrug-resistant Bacteria NCT06652126n/a1 site๐Ÿ“ Lille University Hospital, Lille ยท Tests: Microbiological examinations. Immunogenicity of RSVPreF3 Vaccine in Immunocompromised Persons NCT07050732Phase 21 site๐Ÿ“ Baltimore Johns Hopkins University ยท Tests: Arexvy (2 doses total), Arexvy (3 doses total), Arexvy (1 dose total), Placebo Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune) NCT05026138n/a1 site๐Ÿ“ Bethesda National Institute of Allergy and Infectious Diseases (NIAIโ€ฆ A Study to Learn About Revaccination With a Vaccine Called RSVpreF in Immunocompromised Adults NCT07768345Phase 317 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles Pfizer ยท Tests: RSVpreF Vaccine OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients NCT07406217Phase 24 sites๐Ÿ“ Basel๐Ÿ“ Geneva๐Ÿ“ Lausanne Calmy Alexandra ยท Tests: Paxlovid 5 days, Paxlovid 10 days Third Party Viral Specific T-cells (VSTs) NCT02532452Phase 24 sites๐Ÿ“ Akron๐Ÿ“ Cincinnati๐Ÿ“ Cincinnati Children's Hospital Medical Center, Cincinnati ยท Tests: Viral Specific VST Infusion
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy